Tixel Treatment for Dry Eye Symptoms
Launched by DR LUDGER HANNEKEN · Mar 28, 2022
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
Tixel® (Novoxel®, Israel) is a thermomechanical system developed for fractional treatment. The system is designed for the treatment of soft tissue by direct conduction of heat, enabling fast water evaporation with low thermal damage to the surrounding tissue (such as charring or ablation). The system consists of a handpiece connected to a console. The handpiece applies a therapeutic element, the "tip", fixated on the distal section. The tip is comprised of a gold-plated copper base and a thin-walled titanium alloy cover.
While treating patients for wrinkles, it has been observed that in se...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years
- • 2. Mild to Moderate Periorbital wrinkles
- • 3. OSDI score of at least 23
- • 4. Noninvasive Tear film break up time (NIKBUT) ≤ 10 seconds
- • 5. Willing and able to provide written informed consent.
- • 6. Willing to participate in all study activities and instructions.
- Exclusion Criteria:
- • 1. Pregnancy and breastfeeding
- • 2. Lesions in the periorbital area
- • 3. Acute severe blepharitis
- • 4. Acute conjunctivitis
- • 5. Other concomitant anterior eye disease
About Dr Ludger Hanneken
Dr. Ludger Hanneken is a distinguished clinical trial sponsor with extensive expertise in the field of medical research and development. With a strong commitment to advancing healthcare through innovative clinical studies, Dr. Hanneken leads initiatives that focus on the evaluation of novel therapies and treatment methodologies. His collaborative approach fosters partnerships with leading research institutions and healthcare professionals, ensuring rigorous study design and adherence to regulatory standards. Driven by a passion for improving patient outcomes, Dr. Hanneken’s work contributes significantly to the scientific community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Escaldes Engordany, , Andorra
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials